The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk
Open Access
- 1 January 2021
- journal article
- other
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 59 (1) , 1159-1169
Abstract
Various herbal medicines are thought to be useful in the management of cardiometabolic disease and its risk factors. Ganoderma lucidum (Curtis) P. Karst. (Ganodermataceae), also known as Lingzhi, h...Keywords
Funding Information
- Institutional Development Grant of Caritas Institute of Higher Education (IDG200114)
This publication has 116 references indexed in Scilit:
- Anti-angiotensin converting enzyme (ACE) proteins from mycelia of Ganoderma lucidum (Curtis) P. KarstBMC Complementary and Alternative Medicine, 2013
- Antidiabetic, Antihyperlipidemic and Antioxidant Activities of a Novel Proteoglycan from Ganoderma Lucidum Fruiting Bodies on db/db Mice and the Possible MechanismPLOS ONE, 2013
- Ganoderma lucidum ethanol extract inhibits the inflammatory response by suppressing the NF-κB and toll-like receptor pathways in lipopolysaccharide-stimulated BV2 microglial cellsExperimental and Therapeutic Medicine, 2013
- Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart StudyDiabetology & Metabolic Syndrome, 2012
- Evaluation of Selected Culinary-Medicinal Mushrooms for Antioxidant and ACE Inhibitory ActivitiesEvidence-Based Complementary and Alternative Medicine, 2012
- Antihyperglycemic Effect of Ganoderma Lucidum Polysaccharides on Streptozotocin-Induced Diabetic MiceInternational Journal of Molecular Sciences, 2011
- Effects of Human C-Reactive Protein on Pathogenesis of Features of the Metabolic SyndromeHypertension, 2011
- Medicinal Mushroom Science: History, Current Status, Future Trends, and Unsolved ProblemsInternational Journal of Medicinal Mushrooms, 2010
- A New Class of Natural Glycopeptides with Sugar Moiety-Dependent Antioxidant Activities Derived from Ganoderma lucidum Fruiting BodiesJournal of Proteome Research, 2008
- A Phase I/II Study of Ling Zhi Mushroom Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Aphyllophoromycetideae) Extract in Patients with Coronary Heart DiseaseInternational Journal of Medicinal Mushrooms, 2004